Two Sigma Advisers »

Summit Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $187k 11k 17.49

More positions owned by Two Sigma Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Micron Technology (MU)
Palantir Technologies Cl A (PLTR)
Charles Schwab Corporation (SCHW)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Intuitive Surgical Com New (ISRG)
Boston Scientific Corporation (BSX)
Lockheed Martin Corporation (LMT)
Adobe Systems Incorporated (ADBE)

View all positions for Two Sigma Advisers

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
Vanguard Group
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Geode Capital Management
Polymer Capital Management
Pictet Asset Management Holding SA
Norges Bank Investment Management
Apeiron Capital
TD Asset Management
Standard Life Aberdeen
Charles Schwab Investment Management

View all funds holding Summit Therapeutics